Ectosense careers

Ectosense develops the NightOwl® device, the world smallest, most convenient and accurate home sleep apnea test. Affecting one in three people, sleep disorders are extremely common. The most prevalent one, sleep apnea, leads to great body damage over time, yet more than 4 out of 5 sufferers remain undiagnosed, resulting in more than 200 million undiagnosed cases worldwide. Apart from the personal suffering, a condition such as sleep apnea is linked to many other chronic conditions, resulting in an estimated >$70 billion of increased annual expenses due to the underdiagnosis in the U.S. alone. Highly cumbersome, expensive, and time-consuming diagnostics systems are partly to blame. Patients, caregiver and insurance companies stand to benefit greatly from a solution that holds the capacity to tackle this underdiagnosis more strongly.